Healthcare
WELL Health Remains Attractively Priced Amid Market Recovery
September 19, 2024 04:37 PM EDT | By Team Kalkine MediaWELL Health Technologies Corp, a prominent player in the,healthcare sector,, has shown resilience despite broader economic challenges. The recent adju...
Willow Biosciences Engages in Innovative Project with Leading API Ma...
September 19, 2024 02:32 PM EDT | By Team Kalkine MediaIn the,Healthcare sector,, Willow Biosciences Inc. has announced a second collaboration with a prominent Active Pharmaceutical Ingredient (API) manufa...
Roquefort’s STAT-6 siRNA Effective in Trials, Eyes Licensing
September 19, 2024 01:44 PM EDT | By Team Kalkine MediaRoquefort Therapeutics has recently highlighted significant advancements in its STAT-6 siRNA program, providing an update on promising results obtaine...
Breakthrough Device For Pediatric Sleep Apnea Approved By FDA
September 18, 2024 10:38 AM EDT | By Team Kalkine MediaVivos Therapeutics has announced the receipt of US Food and Drug Administration (FDA) approval for its oral medical device designed to treat moderate...
Immunic Unveils Lead Asset For Multiple Sclerosis At ECTRIMS
September 18, 2024 09:25 AM EDT | By Team Kalkine MediaImmunic Inc has presented significant data on its primary asset, vidofludimus calcium, at the 40th Congress of the European Committee for Treatment an...
Is Now the Right Time to Watch WELL Health Technologies Stock?
September 17, 2024 01:42 PM EDT | By Team Kalkine MediaIn recent years, many high-quality Canadian stocks have been trading at lower prices due to challenging economic conditions and an uncertain stock mar...
MustGrow Partners With Agriculture Canada For Mustard Seed Breakthro...
September 17, 2024 01:03 PM EDT | By Team Kalkine MediaMustGrow Biologics Corp. (,TSXV:MGRO,) has received funding from Agriculture and Agri-Food Canada (AAFC) to explore the potential of mustard-derived i...
Voyageur Pharmaceuticals Appoints New Chief Science Officer
September 17, 2024 12:43 PM EDT | By Team Kalkine MediaVoyageur Pharmaceuticals Ltd (,TSXV:VM,) has announced a significant addition to its executive team with the appointment of Dr. Iryna Saranchova as th...
Lisata Therapeutics Begins Second Cohort Treatment In Bile Duct Canc...
September 17, 2024 12:26 PM EDT | By Team Kalkine MediaLisata Therapeutics Inc,(NASDAQ:LSTA),. has initiated treatment in the second-line cholangiocarcinoma (CCA) cohort of its BOLSTER trial. Cholangiocarc...
Savaria Chief Legal Officer & Corporate Secretary Sylvain Aubry Redu...
September 16, 2024 03:12 PM EDT | By Team Kalkine MediaSavaria Corporation (,TSX:SIS,), a prominent player in the healthcare sector, has recently seen notable insider transactions. Sylvain Aubry, the Chief...
Andlauer Healthcare Group Inc.: Financials Remain Robust Despite Rec...
September 13, 2024 02:13 PM EDT | By Team Kalkine MediaRecent performance data for Andlauer Healthcare Group (,TSX:AND,) has shown a 4.8% decline in its stock value over the past week. This decline may rai...
Immunic CEO Highlights New York MS R&D Day and Vidofludimus Calcium...
September 13, 2024 07:33 AM EDT | By Team Kalkine MediaImmunic Inc,(NASDAQ:IMUX),recently provided an update on its progress in developing vidofludimus calcium, a promising treatment for multiple sclerosis...
Limited Concerns About Cardiol Therapeutics' Cash Burn Rate
September 12, 2024 12:50 PM EDT | By Team Kalkine MediaOwning shares in companies that are not yet profitable can be lucrative, as evidenced by Cardiol Therapeutics,(TSX:CRDL),, which has seen a remarkable...
Risks Remain Elevated as Nova Leap Health Corp. Shares Drop 27%
September 12, 2024 06:47 AM EDT | By Team Kalkine MediaNova Leap Health Corp.,(TSXV:NLH),has recently faced a substantial drop in its share price, with a decline of 27% over the past thirty days. Despite t...
Improved Revenues Needed for iAnthus Capital Holdings, Inc. Stock's...
September 10, 2024 02:47 PM EDT | By Team Kalkine MediaiAnthus Capital Holdings, Inc.,(OTH:ITHUF),has recently demonstrated impressive performance, with its share price showing a notable 33% gain over the...
Cardiol Therapeutics to Present Results from Phase 2 Recurrent Peric...
September 10, 2024 01:53 PM EDT | By Team Kalkine MediaCardiol Therapeutics,(TSX:CRDL),has completed its Phase 2 MAvERIC-Pilot study evaluating the effects of its novel therapy, CardiolRx, on patients with...
Is WELL Health Technologies a High-Risk Opportunity?
September 09, 2024 02:16 PM EDT | By Team Kalkine MediaHoward Marks eloquently highlighted the primary concern in financial management: “The possibility of permanent loss is the risk I worry about... and e...
Risks and Challenges for Lifeist Wellness in the Healthcare Sector
September 06, 2024 03:03 PM EDT | By Team Kalkine MediaThe,healthcare sector,has recently seen significant fluctuations, impacting various companies including Lifeist Wellness Inc. Lifeist Wellness, listed...
Voyageur Pharmaceuticals Advances Diagnostic Products Toward FDA App...
September 05, 2024 03:43 PM EDT | By Team Kalkine MediaIn the,Healthcare sector,, Voyageur Pharmaceuticals has reached a significant milestone with the completion of its innovative diagnostic product formu...
Evaluating Risk Factors for TerrAscend Inc.
September 03, 2024 10:30 AM EDT | By Team Kalkine MediaTerrAscend Inc. operates within the,Healthcare sector,, focusing on cannabis and related products. An evaluation of the company's financial stability...
Canadian AI All-Stars: Unveiling the Top Stocks for 2024